On Tuesday, Plus Therapeutics Inc (NASDAQ: PSTV) was 4.14% up from the session before settling in for the closing price of $0.49. A 52-week range for PSTV has been $0.16 – $2.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 46.51%. When this article was written, the company’s average yearly earnings per share was at 78.40%. With a float of $99.02 million, this company’s outstanding shares have now reached $99.26 million.
Plus Therapeutics Inc (PSTV) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Plus Therapeutics Inc stocks. The insider ownership of Plus Therapeutics Inc is 0.25%, while institutional ownership is 3.19%. The most recent insider transaction that took place on Aug 22 ’25, was worth 53,779. In this transaction Director of this company bought 110,000 shares at a rate of $0.49, taking the stock ownership to the 139,327 shares. Before that another transaction happened on May 15 ’25, when Company’s Director proposed sale 36,666 for $0.55, making the entire transaction worth $20,276.
Plus Therapeutics Inc (PSTV) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.37 earnings per share (EPS) during the time that was better than consensus figure (set at -0.56) by 0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 78.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 62.60% during the next five years compared to 46.51% growth over the previous five years of trading.
Plus Therapeutics Inc (NASDAQ: PSTV) Trading Performance Indicators
You can see what Plus Therapeutics Inc (PSTV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.23, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Plus Therapeutics Inc (PSTV)
Looking closely at Plus Therapeutics Inc (NASDAQ: PSTV), its last 5-days average volume was 5.59 million, which is a drop from its year-to-date volume of 19.27 million. As of the previous 9 days, the stock’s Stochastic %D was 17.52%.
During the past 100 days, Plus Therapeutics Inc’s (PSTV) raw stochastic average was set at 32.35%, which indicates a significant increase from 12.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0854 in the past 14 days, which was higher than the 0.0834 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4503, while its 200-day Moving Average is $0.8296. However, in the short run, Plus Therapeutics Inc’s stock first resistance to watch stands at $0.5336. Second resistance stands at $0.5621. The third major resistance level sits at $0.5851. If the price goes on to break the first support level at $0.4821, it is likely to go to the next support level at $0.4591. Should the price break the second support level, the third support level stands at $0.4306.
Plus Therapeutics Inc (NASDAQ: PSTV) Key Stats
There are 99,265K outstanding shares of the company, which has a market capitalization of 50.15 million. As of now, sales total 5,820 K while income totals -12,980 K. Its latest quarter income was 1,390 K while its last quarter net income were 5,150 K.
